A randomized, controlled, phase 2 trial of nivolumab plus standard-dose or low-dose bevacizumab for recurrent glioblastoma (NAVAL)

被引：0
|
作者：
Ahluwalia, Manmeet Singh
Peereboom, David M.
Ozair, Ahmad
Khosla, Atulya Aman
Rauf, Yasmeen
Nayak, Lakshmi
Ciolfi, Marci
Alban, Tyler
Grabowski, Matthew
Rayman, Pat
Diaz, Marcella
Lathia, Justin
Lee, Eudocia Quant
Wen, Patrick Y.
Reardon, David A.
机构：
[1] Baptist Hlth South Florida, Miami Canc Inst, Miami, FL USA
[2] Cleveland Clin, Cleveland, OH 44106 USA
[3] William Beaumont Univ Hosp, Dept Internal Med, Royal Oak, MI USA
[4] Univ North Carolina Chapel Hill, Chapel Hill, NC USA
[5] Dana Farber Canc Inst, Boston, MA 02115 USA
[6] Cleveland Clin Lerner Res Inst, Cleveland, OH USA
[7] Dana Farber Canc Inst, Div Neurooncol, Boston, MA 02115 USA
[8] Harvard Med Sch, Boston, MA 02115 USA
[9] Dana Farber Canc Inst, Ctr Neurooncol, Boston, MA 02115 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2072
引用
下载
收藏
页数：1
相关论文
共 50 条
  • [21] Comparison of standard-dose and low-dose gemcitabine regimens in pancreatic adenocarcinoma patients: a prospective randomized trial
    Sakamoto, H
    Kitano, M
    Suetomi, Y
    Takeyama, Y
    Ohyanagi, H
    Nakai, T
    Yasuda, C
    Kudo, M
    JOURNAL OF GASTROENTEROLOGY, 2006, 41 (01) : 70 - 76
  • [22] Comparison of standard-dose and low-dose gemcitabine regimens in pancreatic adenocarcinoma patients: a prospective randomized trial
    Hiroki Sakamoto
    Masayuki Kitano
    Yoichirou Suetomi
    Yoshifumi Takeyama
    Harumasa Ohyanagi
    Takuya Nakai
    Chikao Yasuda
    Masatoshi Kudo
    Journal of Gastroenterology, 2006, 41 : 70 - 76
  • [23] Low-dose versus standard-dose gemcitabine infusion and cisplatin for patients with advanced bladder cancer: A randomized phase II trial
    Khaled, H.
    Abu-Taleb, F.
    Haggag, R.
    Zekri, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (07)
  • [24] PHASE I TRIAL OF DOSE ESCALATED RADIOSURGERY PLUS BEVACIZUMAB IN PATIENTS WITH RECURRENT/PROGRESSIVE GLIOBLASTOMA
    Abbassy, Mahmoud
    Missios, Symeon
    Brewer, Cathy
    Peereboom, David
    Ahluwalia, Manmeet
    Neyman, Gennady
    Chao, Samuel
    Suh, John
    Barnett, Gene
    Vogelbaum, Michael
    NEURO-ONCOLOGY, 2014, 16
  • [25] EFFICACY AND SAFETY OF METFORMIN PLUS LOW-DOSE TEMOZOLOMIDE IN PATIENTS WITH RECURRENT OR REFRACTORY GLIOBLASTOMA: A RANDOMIZED, PROSPECTIVE, MULTICENTER, DOUBLE-BLIND, CONTROLLED, PHASE 2 TRIAL
    Yoon, Wan Soo
    Chang, Jong Hee
    Kim, Jeong Hoon
    Kim, Yu Jung
    Jung, Tae Young
    Yoo, Heon
    Kim, Se-Hyuk
    Do-Hyun Nam
    Kim, Tae Min
    Kim, Se Hoon
    Park, Sung Hye
    Lee, Youn Soo
    Kim, Hyeon Woo
    Hong, Yong-Kil
    Yang, Seung Ho
    NEURO-ONCOLOGY, 2023, 25
  • [26] Phase I Trial of Radiosurgery Dose Escalation Plus Bevacizumab in Patients With Recurrent/Progressive Glioblastoma
    Abbassy, Mahmoud
    Missios, Symeon
    Barnett, Gene H.
    Brewer, Cathy
    Peereboom, David M.
    Ahluwalia, Manmeet
    Neyman, Gennady
    Chao, Samuel T.
    Suh, John H.
    Vogelbaum, Michael A.
    NEUROSURGERY, 2018, 83 (03) : 385 - 392
  • [27] Low-dose versus standard-dose gemcitabine infusion and cisplatin for patients with advanced bladder cancer: a randomized phase II trial—an update
    Rasha Haggag
    Kamel Farag
    Fouad Abu-Taleb
    Sameh Shamaa
    Abdel-Rahman Zekri
    Tarek ELBolkainy
    Hussein Khaled
    Medical Oncology, 2014, 31
  • [28] SEDATION FOR EUS: A RANDOMISED PROSPECTIVE TRIAL COMPARING LOW-DOSE PROPOFOL plus REMIFENTANIL, MIDAZOLAM plus MEPERIDINE AND STANDARD-DOSE OF PROPOFOL
    Di Matteo, F.
    Rea, R.
    Pandolfi, M.
    Martino, M.
    Carassiti, M.
    Agro, F.
    Costamagna, G.
    Gabbrielli, A.
    DIGESTIVE AND LIVER DISEASE, 2008, 40 : S24 - S24
  • [29] Low-dose ticagrelor yields an antiplatelet efficacy similar to that of standard-dose ticagrelor in healthy subjects: an open-label randomized controlled trial
    Pan Li
    Ying Gu
    Yawei Yang
    Lizhi Chen
    Junmei Liu
    Lihong Gao
    Yongwen Qin
    Quancai Cai
    Xianxian Zhao
    Zhuo Wang
    Liping Ma
    Scientific Reports, 6
  • [30] Low-dose ticagrelor yields an antiplatelet efficacy similar to that of standard-dose ticagrelor in healthy subjects: an open-label randomized controlled trial
    Li, Pan
    Gu, Ying
    Yang, Yawei
    Chen, Lizhi
    Liu, Junmei
    Gao, Lihong
    Qin, Yongwen
    Cai, Quancai
    Zhao, Xianxian
    Wang, Zhuo
    Ma, Liping
    SCIENTIFIC REPORTS, 2016, 6
12345